FTT can't seem to pull a trick to get the dial of the share price to move.
Probably because of (i) Large Institutional shareholder base (ii) The announcement not getting ahead of themselves :
refer : http://www.tissuetherapies.org/uploads/1 June 2012-CE Marking Progress.pdf
Ann: Phase 2 Trial for Venous Leg Ulcers Nears Completion, page-13
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
